Retraction: MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1 (Oncology Letters (2015) 9 (869-874) DOI: 10.3892/ol.2014.2753);MicroRNA-133a suppresses colorectal cancer cell invasion by targeting fascin1

Oncology Letters

Volumn 9, Issue 2, 2015, Pages 869-874

  Zheng, Keyan ^a   Liu, Weicheng ^a   Liu, Ye ^a   Jiang, Congqing ^a   Qian, Qun ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; Fascin1; Invasion; MicroRNA 133a

Indexed keywords

FASCIN; FASCIN 1; MICRORNA; MICRORNA 133A; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION ASSAY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84918820588     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2021.12905     Document Type: Erratum

References (27)

1. Siegel R, Desantis C and Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin 64: 104-117, 2014.
2. Hammoud SS, Cairns BR and Jones DA: Epigenetic regulation of colon cancer and intestinal stem cells. Curr Opin Cell Biol 25: 177-183, 2013.
3. Okayama H, Schetter AJ and Harris CC: MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis 30 (Suppl 2): 9-15, 2012.
4. Khare S and Verma M: Epigenetics of colon cancer. Methods Mol Biol 863: 177-185, 2012.
5. Qian B, Nag SA, Su Y, et al: MiRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents. Curr Cancer Drug Targets 13: 519-541, 2013.
6. Fabbri M, Calore F, Paone A, Galli R and Calin GA: Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol 754: 137-148, 2013.
7. Wang LK, Hsiao TH, Hong TM, et al: MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. PLoS One 9: e96765, 2014.
8. Qiu T, Zhou X, Wang J, et al: MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett 588: 1168-1177, 2014.
9. Fujiwara T, Katsuda T, Hagiwara K, et al: Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Stem Cells 32: 959-973, 2014.
10. Akanuma N, Hoshino I, Akutsu Y, et al: MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer 110: 189-198, 2014.
11. Guo J, Xia B, Meng F and Lou G: MiR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor. Tumour Biol 35: 1557-1564, 2014.
12. Wang H, An H, Wang B, et al: MiR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Cancer 49: 3924-3935, 2013.
13. Park SH, Song JY, Kim YK, et al: Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells. Int J Oncol 44: 637-646, 2014.
14. Yamakita Y, Matsumura F, Lipscomb MW, et al: Fascin1 promotes cell migration of mature dendritic cells. J Immunol 186: 2850-2859, 2011.
15. Chen MB, Wei MX, Han JY, et al: MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Cell Signal 26: 102-109, 2014.
16. Tsai WC, Chao YC, Sheu LF, Chang JL, Nieh S and Jin JS: Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers 23: 153-160, 2007.
17. Ye JJ and Cao J: MicroRNAs in colorectal cancer as markers and targets: Recent advances. World J Gastroenterol 20: 4288-4299, 2014.
18. Wu ZS, Wang CQ, Xiang R, et al: Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer 12: 51, 2012.
19. Arndt GM, Dossey L, Cullen LM, et al: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9: 374, 2009.
20. Sarver AL, French AJ, Borralho PM, et al: Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9: 401, 2009.
21. Dong Y, Zhao J, Wu CW, et al: Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res 11: 1051-1060, 2013.
22. Wen YH, Yee H, Goswami S and Shukla PS: Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy. Int J Gynecol Pathol 28: 187-192, 2009.
23. Fu H, Hu Z, Wen J, Wang K and Liu Y: TGF-β promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochim Biophys Sin (Shanghai) 41: 648-656, 2009.
24. Chan C, Jankova L, Fung CL, et al: Fascin expression predicts survival after potentially curative resection of node-positive colon cancer. Am J Surg Pathol 34: 656-666, 2010.
25. Machesky LM and Li A: Fascin: Invasive filopodia promoting metastasis. Commun Integr Biol 3: 263-270, 2010.
26. Chiyomaru T, Enokida H, Tatarano S, et al: MiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891, 2010.
27. Kano M, Seki N, Kikkawa N, et al: MiR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.